Form 4: Genpact CEO Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Genpact's CEO, Balkrishan Kalra, exercised stock options and sold shares on December 13, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Genpact CEO, Balkrishan Kalra, executed transactions involving company stock on December 13, 2024.
- He exercised 13,600 employee stock options at a price of $27.65 per share.
- Concurrently, he sold 13,600 common shares at a weighted average price of $44.60 per share, with individual sales ranging from $44.47 to $44.78.
- These transactions were conducted under a Rule 10b5-1 trading plan adopted on September 13, 2024.
- Following these transactions, Mr. Kalra directly owns 267,404 common shares and 56,400 employee stock options.
Sentiment
Score: 5
Explanation: The document reflects routine transactions by an executive under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, often tied to compensation and personal financial planning. The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies like Genpact, similar to plans used by executives at companies such as Accenture and Infosys.
- The vesting schedule of the options, with two tranches vesting on specific dates, is a typical structure for executive stock options, comparable to vesting schedules at other tech and consulting firms.
- The sale of shares after exercising options is a standard practice for executives to realize the value of their compensation, similar to transactions seen at companies like Cognizant and Wipro.
Stakeholder Impact
- The transactions may have a minor impact on the stock price, but are unlikely to cause significant fluctuations due to the pre-planned nature of the sales.
- The transactions do not have a direct impact on employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 01/10/2019 | 50% of the employee stock options vested. |
| 01/10/2021 | The remaining 50% of the employee stock options vested. |
| 09/13/2024 | The 10b5-1 trading plan was adopted by the reporting person. |
| 12/13/2024 | The CEO exercised stock options and sold shares. |
| 12/17/2024 | The Form 4 was signed and filed. |
| 03/31/2026 | Expiration date of the employee stock options. |
Keywords
Genpact, Balkrishan Kalra, stock options, share sale, 10b5-1 plan, insider trading, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.